神经根阻滞与手术治疗腰椎间盘突出继发根性痛的多中心随机对照试验方案
NERVES试验为多中心随机对照试验,计划招募163例来自英国NHS门诊的16-65岁坐骨神经痛患者,随机分配至显微椎间盘切除术或经椎间孔硬膜外类固醇注射(TFESI)。主要结局为随机化后18周Oswestry功能障碍问卷(ODQ)评分,并评估成本效果与生活质量。该试验首次直接比较两种治疗方案的临床与成本效果。
要点
- NERVES试验首次直接比较显微椎间盘切除术与TFESI治疗腰椎间盘突出继发坐骨神经痛。
- 纳入16-65岁、症状持续6周至12个月且至少一种保守治疗无效的患者。
- 主要结局为18周ODQ评分,次要结局包括疼痛、功能障碍、满意度及成本效果。
核心结论
- NERVES试验旨在比较显微椎间盘切除术与TFESI治疗腰椎间盘突出继发坐骨神经痛的临床与成本效果。
- 该试验为首个直接比较这两种治疗方案的随机对照试验,结果可能有助于制定循证治疗策略。
研究设计与样本
- 多中心随机对照试验,从英国NHS门诊招募163例患者,随机分配至显微椎间盘切除术或TFESI组。
- 纳入标准为16-65岁、坐骨神经痛持续6周至12个月、至少一种保守治疗无效且愿意签署知情同意书的患者。
- 排除标准为存在神经功能缺损或既往同节段手术史的患者。
- 分析遵循意向性治疗原则。
关键数值与推荐
- 主要结局为随机化后18周患者报告的ODQ残疾评分。
- 次要结局包括每12周评估的数值疼痛评分、改良Roland-Morris问卷和核心结局指标指数,以及54周的患者满意度。
- 使用EQ-5D-5L和自报费用数据每12周评估成本效果与生活质量,并收集医院 Episode Statistics(HES)数据。
- 收集不良事件数据。
临床怎么用
- 该试验结果可为坐骨神经痛患者选择显微椎间盘切除术或TFESI提供证据依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sciatica is a common condition reported to affect over 3% of the UK population at any time and is often caused by a prolapsed intervertebral disc (PID). Although the duration and severity of symptoms can vary, pain persisting beyond 6 weeks is unlikely to recover spontaneously and may require investigation and treatment. Currently, there is no specific care pathway for sciatica in the National Health Service (NHS), and no direct comparison exists between surgical microdiscectomy and transforaminal epidural steroid injection (TFESI). The NERVES (NErve Root block VErsus Surgery) trial aims to address this by comparing clinical and cost-effectiveness of surgical microdiscectomy and TFESI to treat sciatica secondary to a PID. METHODS/DESIGN: A total of 163 patients were recruited from NHS out-patient clinics across the UK and randomised to either microdiscectomy or TFESI. Adult patients (aged 16-65 years) with sciatic pain endured for between 6 weeks and 12 months are eligible if their symptoms have not been improved by at least one form of conservative (non-operative) treatment and they are willing to provide consent. Patients will be excluded if they present with neurological deficit or have had previous surgery at the same level. The primary outcome is patient-reported disability measured using the Oswestry Disability Questionnaire (ODQ) score at 18 weeks post randomisation and secondary outcomes include disability and pain scales using numerical pain ratings, modified Roland-Morris and Core Outcome Measures Index at 12-weekly intervals, and patient satisfaction at 54 weeks. Cost-effectiveness and quality of life (QOL) will be assessed using the EQ-5D-5 L and self-report cost data at 12-weekly intervals and Hospital Episode Statistics (HES) data. Adverse event data will be collected. Analysis will follow the principle of intention-to-treat. DISCUSSION: NERVES is the first trial to evaluate the comparative clinical and cost-effectiveness of microdiscectomy to local anaesthetic and steroid administered via TFESI. The results of this research may facilitate the development of an evidence-based treatment strategy for patients with sciatica. TRIAL REGISTRATION: ISRCTN, ID: ISRCTN04820368 . Registered on 5 June 2014. EudraCT EudraCT2014-002751-25. Registered on 8 October 2014.
引用
- Wilby MJ, Hopkins C, Bedson E, et al. Nerve root block versus surgery (NERVES) for the treatment of radicular pain secondary to a prolapsed intervertebral disc herniation: study protocol for a multi-centre randomised controlled trial. Trials. 2018. PMID: 30185221. doi:10.1186/s13063-018-2677-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。